| Hans-Günter Meyer-Thompson | Cannabis als Medizin
Medical cannabis for opioid use disorder: The association between state policies and dispensary marketing claims
Medical cannabis for opioid use disorder: The association between state policies and dispensary marketing claims
Cannabis might have benefits for opioid use disorder treatment but it has yet to be FDA-approved for treatment in the United States due to a lack of rigorous research. (Recovery Research Institute, USA, Januar 2021)
https://www.recoveryanswers.org/research-post/medical-cannabis-opioid-use-disorder-association-state-policy-dispensary-marketing/